Presentation information
[WFNMB]
The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » Fukushima Session
Fukushima Session
The progress of development of At-211 targeted alpha particle therapy at Fukushima Medical University and possibilities of combined therapy with external-beam radiation and immunotherapy
Fri. Sep 9, 2022 5:30 PM - 6:30 PM Room1 (Kyoto International Conference Center 1F Main Hall)
Chair：Shunichi Yamashita (Vice president, Fukushima medical university, Fukushima, Japan), Tohru Shiga (Advanced clinical Research Center, Fukushima medical university, Fukushima, Japan)